None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: * Inclusion criteria 1. Child A or B score lower than 9 2 Serum bilirubin level of 5 mg/dL or lower 3. Aspartate aminotransferase (AST) and Alanine aminotransferase (ALT) values of 100 IU/L or lower 4. Serum creatinine value of 1.5 mg/dL or lower 5. International normalized ratio (INR) of 2.0 or low 6. those who provided written informed consent. voluntarily 7. those who are capable of participating in follow up observations during the trial 8 The subjects underwent a washout period and required to be monitored during the trial and to follow the restriction standards of the trial.
Exclusion criteria
Exclusion criteria: * Exclusion criteria 1. Severe neutropenia (absolute neutrophil level of 500/uL or lower) 2. Platelet count less than 50,000/uL 3. Fever, aggravation of liver function, abdominal aneurysm, sepsis, and thrombosis 4. The subjects judged by investigators to have difficulty continuing the trial were also excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| National Cancer Center scoring system | — |
Secondary
| Measure | Time frame |
|---|---|
| Child score and Liver function test;Safety | — |
Countries
Korea, Republic of
Contacts
Daegu Oriental Hospital of Daegu Haany University